We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

This study has been terminated.
(Numbe of eligible patients has been decreased over time.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00592566
First Posted: January 14, 2008
Last Update Posted: January 14, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Thailand Research Fund
Information provided by:
Mahidol University
January 1, 2008
January 14, 2008
January 14, 2008
July 2003
October 2006   (Final data collection date for primary outcome measure)
Survival [ Time Frame: during in hospital admission ]
Same as current
No Changes Posted
Days of mechanical ventilation [ Time Frame: during hospital admission ]
Same as current
Not Provided
Not Provided
 
Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
An Open Randomized Controlled Trial of Desmopressin, and Dexamethasone as Adjunctive Therapy in Patients With Pulmonary Hemorrhage Associated With Leptospirosis

Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand.

Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.

Not Provided
Interventional
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Leptospirosis
Drug: Dexamethasone, desmopressin
200 mg of dexamethasone IV infusion OD for 3 days or 0.3 microgram/ kg of desmopressin in 50 ml of saline, as a 30- minute infusion
Other Name: Minirin
  • No Intervention: 1
    Standard supportive care
  • Experimental: 2
    Dexamethasone treatment
    Intervention: Drug: Dexamethasone, desmopressin
  • Experimental: 3
    Desmopressin treatment
    Intervention: Drug: Dexamethasone, desmopressin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
64
October 2006
October 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • adult patients (> 14 years) with suspected severe leptospirosis
  • patients who presented with acute fever (oral temperature more than 38.00 C for <15 days) in the absence of an obvious focus of infection
  • In the opinion of the attending physician might have pulmonary hemorrhage (i.e. history of hemoptysis, and/ or bilateral nodular or air space infiltration).

Exclusion Criteria:

  • pregnant or breastfeeding
  • those with history of bleeding disorder
  • those who had underlying diseases such as chronic liver disease, diabetes mellitus
  • those who received diuretic or glucocorticoid
Sexes Eligible for Study: All
15 Years to 90 Years   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
 
NCT00592566
DDP2003
RDG4630213
No
Not Provided
Not Provided
Prof. Yupin Suputtamongkol, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Mahidol University
Thailand Research Fund
Principal Investigator: Kanigar Niwattayakul, MD Loei Hospital, Loei, Thailand:
Study Chair: Yupin Suputtamongkol, MD Mahidol University
Mahidol University
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
To Top